An overactive STAT3 is associated with poor prognosis in melanoma patients and drives tumor initiation and malignant progression via induction of several cancer hallmarks, such as apoptosis inhibition, tumor angiogenesis, epithelial–mesenchymal transition (EMT), and stemness. This evidence concerns the gene STAT3 and neoplasm.